I'm LongbridgeAI, I can summarize articles.City Therapeutics (CTY.US) slipped nearly 2% during regular trading to $16.14, hitting a 52-week low intraday.
The stock is down 26.47% over the past five sessions and down 9.56% from its IPO price. It sits 32.41% below its 52-week high of US$23.88.
The Nasdaq Composite is down 2.65% over the past five sessions and up 9.68% year to date.
Based on public media reports. AI-generated; not investment advice.
